Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Incyte Corporation - Common Stock
(NQ:
INCY
)
113.13
-0.31 (-0.27%)
Delayed Quote
Updated: 3:31 PM EDT, Oct 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Incyte Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
Q2 Earnings Roundup: Incyte (NASDAQ:INCY) And The Rest Of The Biotechnology Segment
September 30, 2026
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how biotechnology stocks f...
Via
StockStory
Topics
Artificial Intelligence
Incyte (NASDAQ:INCY) Combines High Growth Momentum With a Breakout Setup
↗
September 30, 2026
Via
Chartmill
Discover the top S&P500 movers in Tuesday's pre-market session.
↗
September 22, 2026
Via
Chartmill
Incyte Maps Post-JAKAFI Growth With Pipeline Push and $4B Sales Target
↗
September 19, 2026
Incyte (NASDAQ:INCY) executives outlined a strategy centered on expanding its non-JAKAFI business, advancing a broader late-stage pipeline and preparing for the loss of exclusivity for JAKAFI after...
Via
MarketBeat
Incyte (NASDAQ:INCY) Combines Minervini Trend Template Strength With High-Growth Momentum
↗
September 18, 2026
Via
Chartmill
Incyte (NASDAQ:INCY) Combines High Growth Momentum with a Breakout Setup
↗
September 08, 2026
Via
Chartmill
Incyte (NASDAQ:INCY) Passes Minervini Trend and High-Growth Screens, But Setup Demands Patience
↗
August 27, 2026
Via
Chartmill
Incyte (NASDAQ:INCY) Combines High Growth Momentum with a Breakout Setup
↗
August 17, 2026
Via
Chartmill
Incyte (NASDAQ:INCY): High Growth Stock Slides on Q2 Beat but Steep Guidance Cut
↗
July 28, 2026
Via
Chartmill
INCYTE CORP (NASDAQ:INCY) Exhibits Perfect Technical Breakout Setup with Strong Ratings
↗
July 27, 2026
Via
Chartmill
3 Growth Stocks to Add to Your Roster
September 17, 2026
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...
Via
StockStory
Topics
Economy
1 Cash-Heavy Stock for Long-Term Investors and 2 We Ignore
September 16, 2026
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion o...
Via
StockStory
Topics
Credit Cards
Incyte (INCY): 3 Reasons We Love This Stock
September 14, 2026
Incyte’s 29% return over the past six months has outpaced the S&P 500 by 15.7%, and its stock price has climbed to $119.95 per share. This was partly thanks ...
Via
StockStory
Topics
Artificial Intelligence
Stocks
Here's How Much $1000 Invested In Incyte 20 Years Ago Would Be Worth Today
↗
September 11, 2026
Incyte (NASDAQ:INCY) has outperformed the market over the past 20 years by 8.25% on an annualized basis producing an average annual return of 17.44%. Currently, Incyte has a market capitalization of...
Via
Benzinga
INCYTE CORP (NASDAQ:INCY) Screens as a High Growth Momentum Stock with a Breakout Setup
↗
July 24, 2026
Via
Chartmill
Incyte Corp (NASDAQ:INCY) Shows Value Stock Strength With Strong Fundamentals and Low Valuation
↗
July 20, 2026
Via
Chartmill
2 Cash-Producing Stocks with Promising Prospects and 1 We Brush Off
September 11, 2026
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Luc...
Via
StockStory
3 Market-Beating Stocks with Competitive Advantages
September 09, 2026
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta y...
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
2 Profitable Stocks with Impressive Fundamentals and 1 We Brush Off
September 04, 2026
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Via
StockStory
Here’s How Much You Would Have Made Owning Incyte Stock In The Last 20 Years
↗
August 20, 2026
Incyte (NASDAQ:INCY) has outperformed the market over the past 20 years by 8.29% on an annualized basis producing an average annual return of 17.52%. Currently, Incyte has a market capitalization of...
Via
Benzinga
1 Unpopular Stock That Deserves Some Love and 2 Facing Headwinds
July 31, 2026
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea...
Via
StockStory
Topics
Supply Chain
Exploring the top movers within the S&P500 index during today's session.
↗
July 28, 2026
Via
Chartmill
Curious about which S&P500 stocks are generating unusual volume on Tuesday? Find out below.
↗
July 28, 2026
Via
Chartmill
Incyte Q2 Earnings Call Highlights
↗
July 28, 2026
Incyte (NASDAQ:INCY) reported second-quarter 2026 net product sales of $1.49 billion, up 40% from a year earlier, supported by demand growth across its marketed portfolio and a one-time non-cash...
Via
MarketBeat
Topics
Earnings
Incyte (NASDAQ:INCY) Posts Better-Than-Expected Sales In Q2 CY2026 But Full-Year Sales Guidance Misses Expectations Significantly
July 28, 2026
Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 37.7% year on ...
Via
StockStory
What To Expect From Incyte’s (INCY) Q2 Earnings
July 26, 2026
Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) will be reporting results this Tuesday before the bell. Here’s what to look for. Incyte beat analy...
Via
StockStory
Topics
Artificial Intelligence
Incyte (INCY): Buy, Sell, or Hold Post Q1 Earnings?
July 15, 2026
Incyte has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 8.6% to $114.25 per...
Via
StockStory
Topics
Stocks
Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks
July 12, 2026
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how biotechnology stocks f...
Via
StockStory
Topics
Artificial Intelligence
2 Fast-Growing Pharmaceutical Stocks to Buy Now
↗
July 08, 2026
Incyte and TG Therapeutics are seeing strong share growth, backed up by booming revenue and earnings.
Via
The Motley Fool
1 Mid-Cap Stock to Research Further and 2 We Avoid
July 03, 2026
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...
Via
StockStory
Topics
Economy
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
